ResearcherGerman Cancer Research CenterActive in the last 2 years
Daniele Lucarelli
Matched on ORCID iD 0000-0002-0393-3848; OpenAlex author ID A5008413164. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 35
2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 3 papers
Papers 5
- Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers. Co-author DOI 10.1016/j.xcrm.2025.102546↗
- Cross-species single-cell atlases chart progression, therapy-driven remodelling and immune evasion in pancreatic cancer Co-author DOI 10.64898/2026.03.19.712924↗
- Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model Co-author DOI 10.64898/2026.06.26.734719↗
- Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time. Co-author DOI 10.1172/jci.insight.169105↗
- AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer. Co-author DOI 10.1007/s00018-022-04638-y↗
Closest collaborators
The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Roland Rad · 5 shared papers, 2022–2026 · strength 0.92
- Paper Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model DOI 10.64898/2026.06.26.734719↗
- Paper Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinst… DOI 10.1016/j.xcrm.2025.102546↗
- Paper Cross-species single-cell atlases chart progression, therapy-driven remodelling and immune evasion in pancreatic cancer DOI 10.64898/2026.03.19.712924↗
- Dieter Saur · 5 shared papers, 2022–2026 · strength 0.92
- Paper Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model DOI 10.64898/2026.06.26.734719↗
- Paper Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinst… DOI 10.1016/j.xcrm.2025.102546↗
- Paper Cross-species single-cell atlases chart progression, therapy-driven remodelling and immune evasion in pancreatic cancer DOI 10.64898/2026.03.19.712924↗
- Stefanie Bärthel · 4 shared papers, 2025–2026 · strength 0.80
- Paper Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model DOI 10.64898/2026.06.26.734719↗
- Paper Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinst… DOI 10.1016/j.xcrm.2025.102546↗
- Paper Cross-species single-cell atlases chart progression, therapy-driven remodelling and immune evasion in pancreatic cancer DOI 10.64898/2026.03.19.712924↗
- Günter Schneider · 4 shared papers, 2022–2026 · strength 0.71
- Paper Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model DOI 10.64898/2026.06.26.734719↗
- Paper Cross-species single-cell atlases chart progression, therapy-driven remodelling and immune evasion in pancreatic cancer DOI 10.64898/2026.03.19.712924↗
- Paper Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time. DOI 10.1172/jci.insight.169105↗
- Maximilian Reichert · 3 shared papers, 2022–2026 · strength 0.50
- Paper Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model DOI 10.64898/2026.06.26.734719↗
- Paper Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time. DOI 10.1172/jci.insight.169105↗
- Paper AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer. DOI 10.1007/s00018-022-04638-y↗
- H. Carlo Maurer · 2 shared papers, 2025–2026 · strength 0.38
- Roland Michael Schmid · 2 shared papers, 2025–2026 · strength 0.38
- İhsan Ekin Demir · 2 shared papers, 2025–2026 · strength 0.38
- Paper Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinst… DOI 10.1016/j.xcrm.2025.102546↗
- Paper Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time. DOI 10.1172/jci.insight.169105↗
- Christian Schneeweis · 2 shared papers, 2022–2026 · strength 0.33
- Chiara Falcomatà · 2 shared papers, 2022–2026 · strength 0.33
- Anna Melissa Schlitter · 1 shared paper, 2026 · strength 0.22
- Raphela A. Ranjan · 1 shared paper, 2026 · strength 0.22
- Julian Frädrich · 1 shared paper, 2026 · strength 0.21
- Achim Krüger · 1 shared paper, 2026 · strength 0.21
- Jan P. Böttcher · 1 shared paper, 2026 · strength 0.21
- Daniel Häußler · 1 shared paper, 2026 · strength 0.21
- Kaan Çifcibaşı · 1 shared paper, 2026 · strength 0.21
- Carmen Mota Reyes · 1 shared paper, 2026 · strength 0.21
- Francisco X. Real · 1 shared paper, 2026 · strength 0.21
- William L. Hwang · 1 shared paper, 2026 · strength 0.21
- Dennis H. Gong · 1 shared paper, 2026 · strength 0.21
- Katja Wittenzellner · 1 shared paper, 2025 · strength 0.17
- Felix Orben · 1 shared paper, 2025 · strength 0.17
- Aristeidis Papargyriou · 1 shared paper, 2025 · strength 0.17
- Bernhard Küster · 1 shared paper, 2025 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.